Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Meiragtx Holdings Plc (NQ: MGTX ) 5.960 +0.150 (+2.58%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Meiragtx Holdings Plc < Previous 1 2 3 Next > MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress October 22, 2024 Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms From MeiraGTx Via GlobeNewswire Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results October 15, 2024 Via Benzinga Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints October 15, 2024 MeiraGTx's clinical study of AAV-GAD for Parkinson's disease showed significant improvements in motor function and quality of life in high- and low-dose groups, with no serious adverse events.... Via Benzinga Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views October 15, 2024 Via Benzinga Exposures Fossil Fuels Recap: MeiraGTx Hldgs Q4 Earnings March 14, 2024 Via Benzinga MeiraGTx Hldgs: Q3 Earnings Insights November 14, 2023 Via Benzinga Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday October 15, 2024 Via Benzinga MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease October 15, 2024 From MeiraGTx Via GlobeNewswire MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference October 09, 2024 Results indicate a potent and effective locally delivered AAV-BDNF gene therapy for the treatment of obesity caused by MC4R deficiency From MeiraGTx Via GlobeNewswire MGTX Stock Earnings: MeiraGTx Hldgs Misses EPS, Misses Revenue for Q2 2024 August 12, 2024 MGTX stock results show that MeiraGTx Hldgs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results August 12, 2024 From MeiraGTx Via GlobeNewswire MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi August 12, 2024 From MeiraGTx Via GlobeNewswire Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose May 21, 2024 Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings. Via Benzinga MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 MGTX stock results show that MeiraGTx Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace MeiraGTx Reports First Quarter 2024 Financial and Operational Results May 09, 2024 From MeiraGTx Via GlobeNewswire MeiraGTx to Participate in Upcoming Investor Conferences April 24, 2024 From MeiraGTx Via GlobeNewswire MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference April 18, 2024 From MeiraGTx Via GlobeNewswire MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q4 2023 March 14, 2024 MGTX stock results show that MeiraGTx Hldgs beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates March 14, 2024 From MeiraGTx Via GlobeNewswire MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals February 13, 2024 MeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of... From MeiraGTx Via GlobeNewswire Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 21, 2023 Via Benzinga Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today? December 21, 2023 MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson (NYSE: JNJ) compan Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 21, 2023 It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! Via InvestorPlace MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million December 21, 2023 From MeiraGTx Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session December 08, 2023 Via Benzinga MeiraGTx to Participate in Upcoming Investor Conferences November 21, 2023 From MeiraGTx Via GlobeNewswire MeiraGTx Announces Third Quarter 2023 Financial and Operational Results November 14, 2023 From MeiraGTx Via GlobeNewswire BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions October 31, 2023 Best Growth Stocks, a leading independent research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a... Via TheNewswire.com BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions October 31, 2023 --News Direct-- Via News Direct < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
